Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 8,494,151 | 8,494,151 | 0 | $428.28M | $459.96M | 25.26% | +$31.68M |
| Praxis Precision Medicines, Inc.(PRAX) | 870,000 | 1,693,219 | +823,219 | $50.06M | $130.31M | 7.16% | +$80.25M |
| Janux Therapeutics, Inc.(JANX) | 1,050,000 | 2,100,000 | +1,050,000 | $47.70M | $112.43M | 6.17% | +$64.73M |
| Arcellx Inc COMMON STOCK | 1,250,000 | 1,300,000 | +50,000 | $104.39M | $99.70M | 5.48% | -$4.69M |
| Edgewise Therapeutics, Inc.(EWTX) | 3,406,534 | 3,406,534 | 0 | $90.92M | $90.95M | 5.00% | +$34.1K |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,470,000 | 3,250,000 | +780,000 | $41.00M | $83.53M | 4.59% | +$42.52M |
| EyePoint, Inc.(EYPT) | 8,325,000 | 8,325,000 | 0 | $66.52M | $62.02M | 3.41% | -$4.50M |
| Rapport Therapeutics, Inc.(RAPP) | 2,940,921 | 2,940,921 | 0 | $60.23M | $52.17M | 2.87% | -$8.06M |
| Crinetics Pharmaceuticals In | 1,100,000 | 1,000,000 | -100,000 | $56.21M | $51.13M | 2.81% | -$5.08M |
| Insmed Incorporated(INSM) | 500,000 | 650,000 | +150,000 | $36.50M | $44.88M | 2.46% | +$8.38M |
| BridgeBio Pharma, Inc.(BBIO) | 1,858,351 | 1,600,000 | -258,351 | $47.31M | $43.90M | 2.41% | -$3.41M |
| Centessa Pharmaceuticals PlcADS | 2,561,600 | 2,561,600 | 0 | $40.96M | $42.91M | 2.36% | +$1.95M |
| Bright Minds Biosciences Inc.(DRUG) | 0 | 1,059,331 | +1,059,331 | $0 | $38.16M | 2.10% | +$38.16M |
| Vaxcyte, Inc.(PCVX) | 1,000,000 | 425,000 | -575,000 | $114.27M | $34.79M | 1.91% | -$79.48M |
| Merus N V | 740,000 | 740,000 | 0 | $36.97M | $31.12M | 1.71% | -$5.85M |
| Helix Acquisition Corp IiCL A | 2,909,000 | 2,909,000 | 0 | $30.40M | $30.54M | 1.68% | +$145.7K |
| Avidity Biosciences Inc | 1,050,000 | 1,050,000 | 0 | $48.23M | $30.53M | 1.68% | -$17.69M |
| Pharvaris N V COM | 1,466,460 | 1,466,460 | 0 | $27.16M | $28.11M | 1.54% | +$953.2K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 2,375,000 | 2,375,000 | 0 | $49.00M | $28.02M | 1.54% | -$20.97M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 500,000 | 500,000 | 0 | $16.45M | $27.68M | 1.52% | +$11.24M |
| Axsome Therapeutics, Inc.(AXSM) | 400,000 | 325,000 | -75,000 | $35.95M | $27.50M | 1.51% | -$8.45M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 2,325,000 | 1,825,000 | -500,000 | $21.62M | $25.42M | 1.40% | +$3.80M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 400,000 | 400,000 | 0 | $20.96M | $22.39M | 1.23% | +$1.44M |
| CG Oncology, Inc.(CGON) | 975,000 | 775,000 | -200,000 | $36.79M | $22.23M | 1.22% | -$14.56M |
| Cargo Therapeutics Inc | 1,182,563 | 1,182,563 | 0 | $21.82M | $17.05M | 0.94% | -$4.77M |
| Alumis Inc | 2,147,396 | 2,147,396 | 0 | $22.93M | $16.88M | 0.93% | -$6.06M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 1,837,739 | +1,837,739 | $0 | $15.80M | 0.87% | +$15.80M |
| ArriVent BioPharma, Inc.(AVBP) | 585,462 | 585,462 | 0 | $13.76M | $15.60M | 0.86% | +$1.84M |
| ABIVAX Société AnonymeADS(ABVX) | 2,130,000 | 2,130,000 | 0 | $24.54M | $15.59M | 0.86% | -$8.95M |
| Engene Holdings Inc COM | 1,000,000 | 2,323,595 | +1,323,595 | $6.60M | $15.45M | 0.85% | +$8.85M |
| BioAge Labs, Inc.(BIOA) | 1,629,529 | 2,629,529 | +1,000,000 | $33.89M | $15.22M | 0.84% | -$18.67M |
| Biomea Fusion, Inc.(BMEA) | 3,570,872 | 3,570,872 | 0 | $36.07M | $13.85M | 0.76% | -$22.21M |
| MBX Biosciences, Inc.(MBX) | 700,000 | 700,000 | 0 | $18.19M | $12.90M | 0.71% | -$5.29M |
| Septerna, Inc.(SEPN) | 0 | 560,000 | +560,000 | $0 | $12.82M | 0.70% | +$12.82M |
| ImmunityBio, Inc.(IBRX) | 0 | 3,000,000 | +3,000,000 | $0 | $7.68M | 0.42% | +$7.68M |
| Enliven Therapeutics Inc | 0 | 250,000 | +250,000 | $0 | $5.63M | 0.31% | +$5.63M |
| ARS Pharmaceuticals, Inc.(SPRY) | 0 | 500,000 | +500,000 | $0 | $5.28M | 0.29% | +$5.28M |
| Yarrow Bioscience Inc(YARW) | 1,394,336 | 1,394,336 | 0 | $2.62M | $4.67M | 0.26% | +$2.05M |
| KALA BIO, Inc.(KALA) | 0 | 603,027 | +603,027 | $0 | $4.19M | 0.23% | +$4.19M |
| GH Research PLC(GHRS) | 593,043 | 593,043 | 0 | $3.97M | $4.15M | 0.23% | +$183.8K |
| Y-Mabs Therapeutics Inc | 1,450,000 | 425,000 | -1,025,000 | $19.07M | $3.33M | 0.18% | -$15.74M |
| UroGen Pharma Ltd.(URGN) | 1,550,000 | 300,000 | -1,250,000 | $19.68M | $3.19M | 0.18% | -$16.49M |
| Omeros Corporation(OMER) | 0 | 300,000 | +300,000 | $0 | $2.96M | 0.16% | +$2.96M |
| Stoke Therapeutics, Inc.(STOK) | 427,163 | 254,161 | -173,002 | $5.25M | $2.80M | 0.15% | -$2.45M |
| Biohaven Ltd.(BHVN) | 401,963 | 55,539 | -346,424 | $20.09M | $2.07M | 0.11% | -$18.01M |
| Verve Therapeutics Inc | 350,000 | 350,000 | 0 | $1.69M | $1.97M | 0.11% | +$280.0K |
| Artiva Biotherapeutics, Inc.(ARTV) | 103,633 | 103,633 | 0 | $1.60M | $1.04M | 0.06% | -$556.5K |
| Rapt Therapeutics Inc | 496,750 | 200,000 | -296,750 | $998.5K | $316.0K | 0.02% | -$682.5K |
| Anaptysbio Inc | 342,465 | 0 | -342,465 | $11.47M | $0 | — | -$11.47M |
| Korro Bio, Inc.(KRRO) | 265,826 | 0 | -265,826 | $8.88M | $0 | — | -$8.88M |
| Longboard Pharmaceuticals In | 2,790,462 | 0 | -2,790,462 | $93.01M | $0 | — | -$93.01M |
| Neurogene Inc.(NGNE) | 107,344 | 0 | -107,344 | $4.50M | $0 | — | -$4.50M |
| Silence Therapeutics plcADS(SLN) | 400,000 | 0 | -400,000 | $7.27M | $0 | — | -$7.27M |